Spectrum Pharmaceuticals, Inc. (SPPI) Social Stream
Spectrum Pharmaceuticals Inc (SPPI) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering SPPI.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
SPPI's average price target has moved down $4.4 over the prior 14 months.
Over the past 49 weeks, SPPI's average upside potential has been 278.33%.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
SPPI Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
Over the past 26 weeks, SPPI's average broker recommendation rating improved by 0.67.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- In terms of how Spectrum Pharmaceuticals Inc fares relative to all US stocks, note that its average analyst price target is higher than 28.81% of that group.
- In the context of all US stocks, Spectrum Pharmaceuticals Inc's upside potential (average analyst target price relative to current price) is higher than 567.68% of them.
- In the context of all US stocks, Spectrum Pharmaceuticals Inc's variance in analysts' estimates is lower than -450.86% of them.
- In the context of stocks in the mid market cap category, Spectrum Pharmaceuticals Inc's number of analysts covering the stock is greater than 79.9% of them.
In the Pharmaceutical Products industry, SIOX, SDGR, and SAVA are the three stocks most similar to Spectrum Pharmaceuticals Inc regarding the price target and analyst recommendation information presented here.
Is SPPI a Buy, Hold or Sell? See the POWR Ratings now!